Completed NA INTERVENTIONAL 1-arm NCT05607667

Clinical Trial in China for Aortic Valve Stenosis

Efficacy and Safety of the J-Valve Transcatheter Aortic Valve Replacement System in Patients With Aortic Stenosis Disease

Sponsor: Genesis Medtech Corporation

Conditions Aortic Stenosis Disease Diseases of Aortic Valve

Interventions Transcatheter aortic valve replacement

Updated 5 times since 2022 Last updated: Jul 23, 2025 Started: Oct 14, 2022 Primary completion: Jul 3, 2024 Completion: Jul 3, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Aortic Stenosis Disease and Diseases of Aortic Valve, this trial is completed. The trial is conducted by Genesis Medtech Corporation and has accumulated 5 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Aug 2025 — Present [monthly]

Completed NA

Status: Unknown → Completed
Dec 2024 — Aug 2025 [monthly]

Unknown NA

Status: Recruiting → Unknown
Sep 2024 — Dec 2024 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Dec 2022 — Jul 2024 [monthly]

Recruiting NA

First recorded

Oct 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Genesis Medtech Corporation

Data source: Genesis Medtech Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Beijing, China , Chongqing, China , Guangdong, China , Nanjing, China , Shanghai, China , Sichuan, China , Suzhou, China , Xi'an, China , Xiamen, China , Yunnan, China and 2 more locations